Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Fuyuhiko

Fuyuhiko Kubota, Ohtsu-Shi JP

Patent application numberDescriptionPublished
20080269455Process for Production of Polybenzazole Polymer and the Polymer - PROBLEMS The present invention relates to a process for producing a polybenzoxazole polymer and provides a process for producing the polybenzoxazole polymer within a short reaction time. 10-30-2008

Fuyuhiko Sakyu, Saitama JP

Patent application numberDescriptionPublished
20100257976Protective Gas Composition For Magnesium/Magnesium Alloy Production And Combustion Preventing Method - There is provided a protective gas composition for preventing combustion of a molten magnesium/magnesium alloy, containing a compound selected from the group consisting of 1,1,1,3,3-pentafluoropropane (HFC-245fa), 1,3,3,3-tetrafluoropropene (OHFC-1234ze), methyl 1,1,2,2-tetrafluoroethyl ether (HFE-254pc), which are fluorine-containing organic compounds, and mixtures thereof; and a carrier gas.10-14-2010
20100263489USE OF A PROTECTIVE GAS COMPOSITION FOR PREVENTING OXIDATION OR COMBUSTION OF MOLTEN MAGNESIUM - A method of using a protective gas composition comprising a fluorine-containing organic compound and a carrier gas for preventing a rapid oxidation or combustion of a molten magnesium/magnesium alloy alloy in a magnesium or magnesium alloy production process.10-21-2010

Fuyuhiko Sakyu, Iruma-Gun JP

Patent application numberDescriptionPublished
20090099395Method for Producing 1,3,3,3-Tetrafluoropropene - There is provided a method for producing 1,3,3,3-tetrafluoropropene. This method includes dehydrofluorinating 1,1,1,3,3-pentafluoropropane in gas phase in the presence of a zirconium compound-carried catalyst in which a zirconium compound is carried on a metal oxide or activated carbon.04-16-2009

Fuyuhiko Tamanoi, Los Angeles, CA US

Patent application numberDescriptionPublished
20100063114INHIBITORS OF PROTEIN PRENYLTRANSFERASES - The present invention is directed to novel compounds. These compounds can be useful in inhibiting the activity of GGTase I. The compounds can also be used as anti-cancer therapeutics including as part of methods for treating cancer, in assays, and in kits.03-11-2010
20100255103Mesoporous Silica Nanoparticles for Biomedical Applications - A submicron structure includes a silica body defining a plurality of pores that are suitable to receive molecules therein, the silica body further defining an outer surface between pore openings of said plurality of pores; and a plurality of anionic molecules attached to the outer surface of the silica body. The anionic molecules provide hydrophilicity to the submicron structure and are suitable to provide repulsion between other similar submicron structures, and the submicron structure has a maximum dimension less than one micron.10-07-2010
20100284924NANO-DEVICES HAVING IMPELLERS FOR CAPTURE AND RELEASE OF MOLECULES - A nanodevice has a containment vessel defining a storage chamber therein and defining at least one port to provide transfer of molecules to or from the storage chamber, and a plurality of impellers attached to the containment vessel. The plurality of impellers are of a structure and are arranged to substantially block molecules from entering and exiting the storage chamber of the containment vessel when the impellers are static and are operable to impart motion to the molecules to cause the molecules to at least one of enter into or exit from the storage chamber of the containment vessel.11-11-2010
20100310465NANO-DEVICES HAVING RELEASABLE SEALS FOR CONTROLLED RELEASE OF MOLECULES - A nanodevice has a containment vessel defining a storage chamber therein and defining at least one port to provide access to and from said storage chamber, and a stopper assembly attached to the containment vessel. The stopper assembly has a blocking unit arranged proximate the at least one port and has a structure suitable to substantially prevent material after being loaded into the storage chamber from being released while the blocking unit is arranged in a blocking configuration. The stopper assembly is responsive to the presence of a predetermined stimulus such that the blocking unit is released in the presence of the predetermined stimulus to allow the material to be released from the storage chamber. The predetermined stimulus is a predetermined catalytic activity that is suitable to at least one of cleave, hydrolyze, oxidize, or reduce a portion of the stopper assembly, and the nanodevice has a maximum dimension of about 1 μm.12-09-2010